Accumulating evidence has also indicated that different kinases, including epidermal growth factor receptor (EGFR), HER2, and/or nuclear factor-κ B, are correlated with the development of cisplatin resistance in bladder cancers [31]. Here, EGFR is linked to urinary bladder carcinoma.